ICD-10-CM Code for Skin Tags: From Clinical Diagnosis to Reimbursement

On the surface, a skin tag—or acrochordon in clinical terms—is one of the most common and seemingly simple dermatological findings. These small, soft, benign growths affect nearly half the adult population, often appearing in areas of friction like the neck, underarms, and groin. For the patient, they can be a minor cosmetic annoyance or a source of irritation when caught on clothing or jewelry. For the clinician, their diagnosis is often immediate and straightforward. However, beneath this clinical simplicity lies a world of administrative and financial complexity, all of which hinges on the correct application of a single code in a vast medical classification system: the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).

Bridging the Gap Between a Simple Growth and Complex Coding

 

The journey from identifying a skin tag in an examination room to receiving proper reimbursement from an insurance payer is a meticulous process governed by rules, regulations, and codes. A physician sees a fibroepithelial polyp; a medical coder must translate this clinical term into a universally recognized alphanumeric code. This translation is not merely clerical work; it is the fundamental language of modern healthcare. It tells the story of the patient’s condition, justifies the medical necessity of a procedure, and allows for the collection of valuable data for research and public health monitoring. An error in this translation, such as using the wrong code or failing to document the proper justification, can lead to claim denials, financial losses for the practice, and frustrating administrative burdens.

This comprehensive guide is dedicated to demystifying the entire process surrounding the ICD-10-CM code for skin tags. We will venture far beyond simply stating the code itself. We will perform a deep dive into the clinical nature of acrochordons, explore the structure and logic of the ICD-10-CM system, dissect the primary code and its nuances, and walk through real-world scenarios that coders, billers, and clinicians face every day.

 

The Critical Role of ICD-10-CM in Modern Healthcare

 

Implemented in the United States in 2015, the ICD-10-CM system represented a monumental shift from its predecessor, ICD-9-CM. With its nearly 70,000 codes, it offers a level of granularity and specificity that allows healthcare providers to capture a much more detailed picture of patient diagnoses. This specificity is paramount. It allows us to differentiate between a simple, asymptomatic skin tag and one that is inflamed, bleeding, and causing significant patient discomfort—a distinction that is crucial for establishing medical necessity and securing reimbursement. Understanding this system is no longer optional; it is an essential competency for anyone involved in the healthcare revenue cycle.

 

Who This Guide Is For

 

This article is designed to be an authoritative resource for a wide audience:

• Medical Coders and Billers: You are on the front lines of the revenue cycle. This guide will provide you with the in-depth knowledge and specific examples needed to code for skin tags accurately, defend against denials, and optimize your workflow.
• Dermatologists, Primary Care Physicians, and Other Clinicians: Your clinical documentation is the foundation upon which all coding and billing are built. This guide will help you understand what information is critical to include in your notes to support the codes used and justify the medical necessity of procedures.
• Practice Managers and Administrators: You oversee the financial health of your practice. A thorough understanding of the coding and reimbursement landscape for common procedures like skin tag removal is vital for minimizing claim denials and ensuring financial stability.
• Students and Educators: Whether you are studying medical coding, nursing, or medicine, this guide provides a practical, real-world application of diagnostic coding principles.

Join us as we explore every facet of this topic, transforming a simple code into a comprehensive understanding of clinical practice, documentation, and the healthcare revenue cycle.

 

Chapter 1: Understanding Skin Tags (Acrochordons): A Clinical Deep Dive

 

Before a single code can be assigned, a solid clinical understanding of the condition is essential. Medical coding is not an abstract process; it is the direct reflection of a clinical reality. An accurate code is born from an accurate diagnosis and a comprehensive understanding of the patient’s condition. In this chapter, we will delve into the biology, appearance, and clinical significance of acrochordons.

 

2.1. Defining the Acrochordon: More Than Just Skin

 

A skin tag, known clinically as an acrochordon, is a benign (non-cancerous) tumor that protrudes from the surrounding skin, typically on a thin stalk called a peduncle. They are incredibly common, with studies suggesting that up to 50-60% of individuals will develop at least one skin tag by the age of 70.

While colloquially called “skin tags,” the medical literature uses several more precise terms that are important for coders and clinicians to recognize, as they may appear in pathology reports or clinical notes.

• Synonyms and Nomenclature:

  • Fibroepithelial Polyp (FEP): This is perhaps the most accurate descriptive term. “Fibro” refers to the fibrous connective tissue, and “epithelial” refers to the overlying skin layer (epidermis). “Polyp” describes its pedunculated, outward-growing shape. When you see this term in a physician’s note, it is synonymous with an acrochordon.

  • Soft Fibroma (Fibroma Molle): This term emphasizes the soft, fleshy texture of the lesion and its fibrous composition. It is another accepted synonym for a skin tag.

  • Cutaneous Tag/Papilloma: These are less formal but still common descriptive terms that refer to the same entity.

Understanding these synonyms is critical. The ICD-10-CM index cross-references these terms, but a coder’s ability to recognize them in documentation ensures that the correct diagnosis is captured without needing to query the physician unnecessarily.

 

2.2. Histopathology: A Microscopic Examination

 

To truly understand what a skin tag is, we must look at it under a microscope. A pathologist’s report following a biopsy or excision of a skin tag will describe its key features. This microscopic view confirms the benign nature of the lesion and definitively distinguishes it from other skin growths.

• The Fibrovascular Core: The central “stalk” or core of the skin tag is composed of loosely arranged collagen fibers (the “fibro-” part) and numerous capillaries and small blood vessels (the “vascular” part). This composition is what gives the tag its soft, pliable texture and explains why it can bleed profusely when snagged or cut. In some larger tags, mature fat cells (adipocytes) may also be present.

• The Overlying Epidermis: The core is covered by a layer of epidermis (the outermost layer of skin), which is typically normal or may show some degree of flattening (atrophy) or gentle thickening (acanthosis). The pigment-producing cells (melanocytes) are usually present in normal numbers, which is why skin tags are typically flesh-colored or slightly darker (hyperpigmented). The absence of abnormal cell nests or significant melanocytic activity helps confirm its benign nature.

 

2.3. Etiology and Pathophysiology: The Driving Forces Behind Their Growth

 

The exact cause of skin tags is not fully understood, but research points to a multifactorial process involving a combination of mechanical, metabolic, and genetic factors.

• The Friction Theory: The most widely accepted theory is that skin tags develop in areas of chronic friction, where skin rubs against skin or clothing. This explains their high prevalence in intertriginous areas (skin folds) such as the axillae (underarms), neck, inframammary region (under the breasts), and groin. This constant irritation is thought to stimulate the overgrowth of the collagen and blood vessels that form the tag.
• The Metabolic Connection: Insulin Resistance and Diabetes: A growing body of evidence has established a strong association between the presence of multiple skin tags and metabolic syndrome, particularly insulin resistance. Insulin, in high concentrations, can act as a growth factor. It binds to insulin-like growth factor 1 (IGF-1) receptors on skin cells (keratinocytes and fibroblasts), promoting their proliferation. This leads to the epidermal and dermal overgrowth seen in acrochordons. The presence of numerous skin tags, especially in a younger, overweight individual, should prompt a clinician to consider screening for type 2 diabetes or pre-diabetes.
• Hormonal Influences: Pregnancy and Growth Factors: Hormonal shifts are also implicated. It is common for pregnant women to develop new skin tags or notice an increase in the size and number of existing ones. This is attributed to elevated levels of hormones like estrogen and progesterone, as well as various growth factors that circulate during pregnancy. Similarly, patients with acromegaly, a condition caused by excess growth hormone, often exhibit numerous large skin tags.
• Genetic Predisposition: Skin tags often run in families, suggesting a genetic component. While no specific gene has been identified, it is common for individuals to report that their parents or siblings also have them. Certain genetic syndromes, like Birt-Hogg-Dubé syndrome, are also associated with multiple fibrofolliculomas and acrochordons.
• The Controversial Link to Human Papillomavirus (HPV): The role of HPV in the etiology of skin tags is debated. Some studies have found HPV DNA (particularly low-risk types 6 and 11) within skin tags, suggesting the virus may play a causative or contributory role, similar to its role in common warts. However, other studies have failed to find this association, and many researchers believe the presence of HPV may be an incidental finding rather than a cause. At present, the link is not definitively established.

 

2.4. Clinical Presentation: Identifying Skin Tags

 

Clinically, the diagnosis of a skin tag is usually made by visual inspection. Their characteristic appearance leaves little room for doubt in most cases.

• Morphology: Size, Shape, and Color:
  • Size: They can range from very small (1 mm) to quite large (up to 5 cm in diameter), though most are in the 2-5 mm range.
  • Shape: They are classically pedunculated, meaning they are attached to the skin by a thin stalk. They can be smooth and round, or they may have a more irregular, wrinkled surface. Some may be more sessile, meaning they have a broader base.
  • Color: Most are flesh-colored or slightly hyperpigmented (tan or light brown). If the stalk of a skin tag becomes twisted, it can cut off the blood supply, causing the tag to become thrombosed and turn dark red, purple, or black. This can be alarming to the patient and may be mistaken for a more serious lesion.
• Common Anatomical Locations:
  • Axillae (armpits)
  • Neck (especially the lateral aspects)
  • Inframammary region
  • Groin and inguinal folds
  • Eyelids
• Symptoms: When a Benign Lesion Becomes a Problem: While inherently benign, skin tags can become symptomatic, which is the key to establishing medical necessity for their removal. Symptoms include:
  • Irritation: From rubbing against clothing, jewelry, or seatbelts.
  • Pain or Bleeding: If they are snagged or their stalk becomes twisted (torsion).
  • Cosmetic Concern: This is the most common reason patients seek removal, but it is not considered medically necessary by payers.
  • Visual Obstruction: A large skin tag on an eyelid can interfere with the field of vision.

 

2.5. Epidemiology: Who Gets Skin Tags and Why?

 

The prevalence of acrochordons increases with age. They are rare in children but begin to appear in early adulthood and become increasingly common after the age of 40. By age 70, over half of the population may be affected. There appears to be an equal distribution between males and females, though women may be more likely to seek treatment for cosmetic reasons. The prevalence is significantly higher in individuals who are obese and in those with type 2 diabetes mellitus, reinforcing the strong link to metabolic factors.

 

2.6. The Crucial Step: Differential Diagnosis

 

While 99% of skin tags are easily identified, a clinician must always consider other lesions that can mimic their appearance. This is particularly important for atypical-looking lesions. An incorrect diagnosis can lead to improper treatment and, more importantly, a missed diagnosis of a potentially malignant condition.

• Neurofibromas: These are benign nerve sheath tumors that can appear as soft, flesh-colored papules. They are typically sessile (broad-based) rather than pedunculated. When pressed, they may feel like they are retracting into the skin (the “buttonhole” sign). The presence of multiple neurofibromas is a hallmark of Neurofibromatosis type 1 (NF1).
• Benign Melanocytic Nevi (Moles): An intradermal nevus, in particular, can be a soft, flesh-colored, raised papule that can be confused with a skin tag. Nevi are growths of melanocytes (pigment cells) and are typically present earlier in life.
• Seborrheic Keratoses: These common benign growths are often described as having a “stuck-on” appearance and a waxy or greasy surface. While usually pigmented, smaller, flesh-colored seborrheic keratoses in skin folds can resemble acrochordons.
• Verruca Vulgaris (Common Warts): Warts caused by HPV can sometimes be pedunculated (filiform warts), especially on the face and neck. They tend to have a more irregular, hyperkeratotic (rough) surface compared to the smoother surface of a typical skin tag.
• Molluscum Contagiosum: These viral lesions are typically small, dome-shaped papules with central umbilication (a small central dimple), which helps distinguish them from skin tags.
• Malignant Mimics (The Rare but Critical Considerations): In very rare instances, a skin cancer can masquerade as a skin tag. A pedunculated basal cell carcinoma, squamous cell carcinoma, or even an amelanotic (non-pigmented) melanoma could potentially mimic an irritated or unusual-looking skin tag. Any lesion that is growing rapidly, bleeding without trauma, ulcerating, or has an unusual color or texture should be considered for biopsy to rule out malignancy.

This thorough clinical foundation is not just academic; it is the bedrock upon which accurate coding is built. The terms used, the symptoms documented, and the differential diagnoses considered all play a role in painting a complete picture that justifies the final ICD-10-CM code assignment.

 

Chapter 2: An Introduction to the ICD-10-CM Coding System

 

To correctly code for a skin tag, one must first understand the language and structure of the coding system itself. The ICD-10-CM is not merely a list of diseases; it is a highly organized, hierarchical classification system with its own grammar, syntax, and rules. This chapter provides the essential context needed to navigate the system effectively.

 

3.1. A Brief History: From the Bertillon Classification to ICD-10-CM

 

The concept of systematically classifying diseases dates back to the 18th century, but the system we use today has its roots in the “International List of Causes of Death,” developed by Jacques Bertillon in the 1890s. This list was adopted internationally and underwent periodic revisions. The World Health Organization (WHO) took over management of the system after World War II, expanding it to cover morbidity (illness) in addition to mortality (death). This led to the International Classification of Diseases (ICD).

The United States has historically used a “Clinical Modification” (CM) of the WHO’s ICD system to better suit its reimbursement and data needs. For decades, healthcare in the U.S. ran on ICD-9-CM. However, with its outdated terminology and limited code set (around 14,000 codes), it could no longer keep pace with advances in medicine. On October 1, 2015, the U.S. healthcare system officially transitioned to ICD-10-CM, a vastly expanded and more specific system with approximately 70,000 codes.

 

3.2. Anatomy of an ICD-10-CM Code

 

Every ICD-10-CM code has a specific structure that conveys information. Understanding this structure is key to finding and interpreting codes correctly.

• Chapters, Blocks, and Categories: The codes are organized into 21 chapters, most of which are based on body systems (e.g., Chapter 12 for Skin) or etiology (e.g., Chapter 2 for Neoplasms). Within each chapter, codes are grouped into blocks of related conditions.
• The Code Structure: Codes can be between 3 and 7 characters long.
  • Character 1: Is always a letter.
  • Character 2: Is always a number.
  • Character 3: Is always a number.
  • Characters 4-6: Can be letters or numbers. These characters provide greater detail and specificity regarding the site, etiology, or manifestation of the condition.
  • Character 7: The 7th character extender is used in certain chapters (like musculoskeletal and injury) to provide information about the episode of care (e.g., A for initial encounter, D for subsequent encounter).

The first three characters (e.g., L91) represent the “category” of the disease. Any character after the third adds more specificity. A three-character code is only used if it is not further subdivided. However, if a code has subcategories, the most specific code must always be used.

• The Importance of Laterality and Specificity: One of the major advantages of ICD-10-CM is its ability to specify laterality (right, left, bilateral). For example, there are different codes for a fracture of the right tibia versus the left tibia. This level of detail was largely absent in ICD-9-CM.

 

3.3. The Power of Granularity: Why ICD-10-CM Matters

 

The transition to ICD-10-CM was a massive undertaking, but it provides significant benefits that impact all areas of healthcare.

• Impact on Reimbursement: Payer systems are built around ICD-10-CM codes. They use the specificity of the code to determine medical necessity and payment levels. A vague or incorrect code is a common reason for a claim to be denied. For skin tags, the ability to document and code for irritation or inflammation is what often separates a covered procedure from a non-covered cosmetic one.
• Value in Research and Public Health: The detailed data captured by ICD-10-CM is invaluable for researchers and public health officials. It allows them to track disease prevalence with greater accuracy, monitor the outcomes of treatments, identify public health threats, and conduct more meaningful epidemiological studies. For example, researchers can use ICD-10-CM data to study the correlation between acrochordons (L91.8) and type 2 diabetes (E11.-).

 

3.4. Navigating the Official Coding Guidelines

 

The use of ICD-10-CM is governed by the ICD-10-CM Official Guidelines for Coding and Reporting, which are maintained by the Cooperating Parties (the American Hospital Association, the American Health Information Management Association, the Centers for Medicare & Medicaid Services, and the National Center for Health Statistics). These guidelines are the definitive set of rules for assigning codes and are considered HIPAA standards. They provide instructions on sequencing, code selection, and the interpretation of conventions used in the manual, such as:

• NEC (“Not Elsewhere Classifiable”): This abbreviation is used when the physician’s documentation provides specific details for which no unique code exists.
• NOS (“Not Otherwise Specified”): This is the equivalent of “unspecified” and should only be used when the physician’s documentation is insufficient to assign a more specific code.

A solid understanding of these foundational principles of the ICD-10-CM system is the prerequisite for moving on to the specific code for skin tags. It provides the context in which all coding decisions are made.

 

Chapter 3: The Primary ICD-10-CM Code for Skin Tags: L91.8

 

With a firm grasp of the clinical nature of skin tags and the structure of the ICD-10-CM system, we can now focus on the specific code used to report this diagnosis. The primary, most commonly used code for a typical skin tag is L91.8.

 

4.1. Locating the Code in the Tabular List

 

To understand the meaning of L91.8, we must trace its position within the hierarchy of the ICD-10-CM Tabular List. This contextualizes the code and clarifies what it represents.

• Chapter 12: Diseases of the Skin and Subcutaneous Tissue (L00-L99) This is the logical starting point for most dermatological conditions. It covers everything from infections (L00-L08) to inflammatory conditions (L20-L30) to disorders of skin appendages (L60-L75).
• Block: Other disorders of the skin and subcutaneous tissue (L80-L99) Within Chapter 12, this block is a sort of “catch-all” for conditions that don’t fit into the more specific categories like dermatitis or bullous disorders. It includes conditions like vitiligo (L80), calluses (L84), and pressure ulcers (L89).
• Category: L91 – Hypertrophic disorders of the skin This three-character category is dedicated to conditions characterized by the overgrowth or thickening of skin components. It includes codes for keloid scars (L91.0) and other atrophic conditions. This is the correct “family” for skin tags, which are fundamentally an overgrowth of dermal and epidermal tissue.

 

4.2. Deconstructing L91.8: “Other hypertrophic disorders of the skin”

 

The final code, L91.8, is reached by selecting the appropriate subcategory under L91.

• The Code: L91.8
• The Official Description: Other hypertrophic disorders of the skin
• What Does “Hypertrophic” Mean Here? In pathology, “hypertrophy” refers to an increase in the size of cells, while “hyperplasia” refers to an increase in the number of cells. A skin tag is technically a hyperplastic process. However, in the context of ICD-10-CM, “hypertrophic disorders” is used as a broader clinical term to describe conditions involving thickening or overgrowth of the skin. L91.8 is the designated code for these specific benign overgrowths that are not classified elsewhere.
• Official Code Description and Inclusions: The power of ICD-10-CM lies in its indexing. If you look up “Tag, skin” in the Alphabetic Index, it will direct you to L91.8. Furthermore, the Tabular List under code L91.8 includes specific synonyms and related terms, confirming its appropriate use. These are often referred to as “inclusion terms.”
  • Inclusion Terms for L91.8:
    • Cutaneous tag
    • Fibroepithelial polyp
    • Skin tag

  The presence of “Fibroepithelial polyp” as an inclusion term is particularly important. It confirms that L91.8 is the correct code to use when a pathology report identifies a lesion with this terminology, even if the clinician’s note simply said “skin tag.” This creates a consistent link between the clinical diagnosis and the histopathological confirmation.

 

4.3. Understanding the Instructional Notes: Excludes1 and Excludes2

 

Instructional notes are one of the most critical and often overlooked aspects of accurate coding. They provide rules about which codes can and cannot be reported together.

• Excludes1: “Not Coded Here” An Excludes1 note means the two conditions cannot be reported together under any circumstances. The conditions listed in an Excludes1 note are mutually exclusive. Code L91.8 does not have any Excludes1 notes directly under it, but the parent category L91 does. For example, L91 has an Excludes1 note for certain congenital malformations, meaning you would not use a code from L91 to describe a congenital skin issue.
• Excludes2: “Not Included Here” An Excludes2 note is more flexible. It means the condition listed is not part of the code being examined, but a patient may have both conditions at the same time. When an Excludes2 note is present, it is acceptable to use both the original code and the excluded code together if the patient has both conditions and they are documented. Under the L91 category, there is an Excludes2 note for:
  • Excludes2: hypertrophic conditions of skin due to yaws (A66.6) This means that if a patient has skin thickening specifically caused by the infectious disease Yaws, you would use code A66.6. The Excludes2 note implies that it’s possible, though unlikely, for a patient to have both Yaws-related skin issues and a separate, unrelated skin tag, in which case both codes could be reported.

By dissecting L91.8 and its place in the ICD-10-CM hierarchy, we establish it as the definitive, primary code for uncomplicated acrochordons. The next step is to apply this knowledge to the complexities of real-world clinical encounters.

---

 

Chapter 4: Advanced Coding Scenarios and Clinical Documentation Integrity

 

Assigning the code L91.8 is often just the beginning. The real art of medical coding lies in capturing the full clinical picture, justifying medical necessity, and ensuring the physician’s documentation supports the codes reported. This chapter explores various scenarios, moving from the simple to the complex.

 

5.1. Scenario 1: The Simple, Asymptomatic Skin Tag

 

• The Case: A 55-year-old male presents for his annual physical. During the exam, he points out several small, flesh-colored skin tags on his neck that have been present for years. They do not bother him, but he asks if they can be removed. The physician agrees to remove them for cosmetic reasons at a future visit.
• Diagnosis: L91.8 (Other hypertrophic disorders of the skin). This is the correct diagnosis for the skin tags.
• Procedure: The removal would be considered cosmetic.
• Coding/Billing Implications: Because the tags are asymptomatic and the reason for removal is purely cosmetic, insurance will not cover the procedure. The patient would be informed of the cost and would be expected to pay out-of-pocket. The claim submitted would still use L91.8 as the diagnosis, but the payer would deny it based on the lack of medical necessity.
• Documentation Example:
  

  S: Patient notes multiple “tags” on neck, present for years. Denies pain, bleeding, or irritation. Requests cosmetic removal. O: Exam of the neck reveals approximately 8 small (2-3mm), soft, pedunculated, normo-pigmented papules consistent with acrochordons. No signs of inflammation, torsion, or bleeding. A: Acrochordons of the neck. P: Discussed cosmetic nature of lesions. Patient understands removal is not medically necessary and will not be covered by insurance. Will schedule elective cosmetic removal via snip excision.

 

5.2. Scenario 2: The Irritated, Inflamed, or Bleeding Skin Tag

 

• The Case: A 62-year-old female presents with a chief complaint of a “painful spot” under her left arm. She reports a skin tag has been present for years, but it recently became caught on her bra strap and is now red, swollen, and has bled intermittently.
• Establishing Medical Necessity: This is the key difference. The patient’s symptoms—pain, irritation, bleeding—elevate this from a cosmetic issue to a medically necessary problem.
• Diagnosis Coding:
  • Primary Diagnosis: L91.8 (Other hypertrophic disorders of the skin). This identifies the underlying lesion.
  • Laterality: While L91.8 itself does not have laterality, the clinical documentation must specify the location (left axilla).
  • Sequencing Secondary Codes: You do not typically need to add a separate code for “pain” or “irritation” as these symptoms are integral to establishing the medical necessity for treating the primary diagnosis (L91.8). The documentation is what tells the story. The payer’s policy will specify what symptoms justify removal. Documenting that the lesion is “symptomatic,” “painful,” “inflamed,” or “bleeding due to trauma from clothing” is crucial.
• Documentation Example:
  

  S: Patient presents with painful lesion in the left axilla. Reports a known skin tag became snagged on clothing 3 days ago. It is now tender to the touch and has bled on her shirt. O: In the left axillary vault, there is a 6mm pedunculated, erythematous, and edematous fibroepithelial polyp. Base is inflamed. No purulent drainage. A: Irritated acrochordon, left axilla. P: Risks, benefits, and alternatives discussed. Patient consents to removal. The area was prepped with alcohol. 1% lidocaine was injected for local anesthesia. The lesion was removed at its base via snip excision. Hemostasis achieved with aluminum chloride. Bandage applied. Patient tolerated well. Specimen sent for pathology to confirm diagnosis.

This documentation clearly establishes why the removal was not cosmetic.

 

5.3. Scenario 3: Location-Specific Coding Nuances

 

While L91.8 is the workhorse code, certain anatomical locations have more specific codes that should be used instead. Using a general code when a more specific one is available is a common coding error.

• Eyelid Skin Tags:
  • A skin tag on the eyelid is not coded with L91.8. Instead, you should look in Chapter 7: Diseases of the Eye and Adnexa (H00-H59).
  • Correct Code: H02.82 – Other specified disorders of eyelid. This category has sub-codes for laterality. For example, a skin tag on the right upper eyelid would be H02.821.
  • Rationale: The ICD-10-CM system prioritizes site-specificity. A lesion on a specialized structure like the eyelid is classified under the chapter for that body system. This is especially important if the lesion is causing a functional problem, such as obstructing vision (which would be documented to further support medical necessity).
• Anal Skin Tags:
  • Anal skin tags are often residual flaps of skin left behind after a thrombosed external hemorrhoid has resolved. They are anatomically and etiologically distinct from acrochordons found elsewhere.
  • Correct Code: K64.5 (Perianal skin tags). This code is found in Chapter 11: Diseases of the Digestive System (K00-K95).
  • Rationale: Again, this is a matter of anatomical specificity and differing etiology. Using L91.8 for an anal tag would be incorrect.

 

5.4. Scenario 4: Skin Tags as a Manifestation of Systemic Disease

 

• The Case: A 45-year-old obese male with poorly controlled type 2 diabetes presents for a follow-up. He has numerous, large acrochordons on his neck and in both axillae, many of which are irritated.
• Coding Principle: The “Code First” rule. When a condition is a manifestation of an underlying disease, the ICD-10-CM guidelines often instruct the coder to sequence the underlying disease first, followed by the manifestation.
• Diagnosis Coding:
  1. E11.628 (Type 2 diabetes mellitus with other skin complications): This code identifies the underlying systemic disease that is contributing to the skin issue.
  2. L91.8 (Other hypertrophic disorders of the skin): This code identifies the specific skin manifestation.
• Rationale: This coding sequence tells the complete story. It doesn’t just say the patient has skin tags; it says the patient has skin tags as a known complication of their diabetes. This level of detail is crucial for data analysis and can also support the medical necessity of managing the skin lesions as part of the overall diabetes management plan.
• Documentation Example:
  

  A:

  1. Poorly controlled Type 2 Diabetes Mellitus with skin complications.
  2. Multiple symptomatic acrochordons of neck and axillae, likely exacerbated by insulin resistance.

 

5.5. The Golden Rule: The Importance of Physician Documentation

 

All accurate coding begins and ends with clear, concise, and complete physician documentation. A coder can only code what is documented in the medical record.

• Elements of Strong Documentation for Skin Tag Removal:
  • Location: Be specific (e.g., “right lateral neck,” “left axillary fold”).
  • Size: Approximate size of the lesion(s).
  • Number of Lesions: This is crucial for selecting the correct CPT® code.
  • Morphology: Describe the lesion (e.g., “pedunculated,” “flesh-colored”).
  • The “Why”: This is the most critical element for reimbursement. Document the symptoms clearly: “patient reports irritation from shirt collar,” “lesion is frequently snagged and has bled,” “causes pain with movement.” Simply stating “patient wants it removed” is the hallmark of a cosmetic procedure.

 

Chapter 5: Billing, Reimbursement, and CPT® Codes

 

Once the correct ICD-10-CM code is selected, it must be paired with a procedure code from the Current Procedural Terminology (CPT®) system. This pairing on a claim form tells the payer what was wrong with the patient (the diagnosis) and what was done about it (the procedure).

 

6.1. The Great Divide: Medical Necessity vs. Cosmetic Procedures

 

This is the single most important concept in billing for skin tag removal. Payers, including Medicare and private insurance companies, will not pay for services that are not medically necessary. A procedure is considered cosmetic if its sole purpose is to improve the patient’s appearance.

• Defining Medical Necessity for Skin Tag Removal: To be considered medically necessary, the removal must be for one of the following documented reasons:
  • The lesion is causing symptoms such as bleeding, pain, or intense itching.
  • The lesion is recurrently inflamed or infected.
  • The lesion is located in an area subject to recurrent trauma (e.g., belt line, bra line, collar line).
  • The lesion is suspicious for malignancy and requires removal for biopsy.
  • The lesion obstructs a body orifice or interferes with vision.

 

 Medical Necessity Checklist for Acrochordon Removal

Criteria	Required Documentation Example	Status
Asymptomatic Lesion	“Patient requests removal for cosmetic reasons.”	Not Covered
Recurrent Irritation/Trauma	“Lesion located in right axilla, becomes painful and inflamed from friction with clothing.”	Covered
Bleeding	“Patient reports the skin tag on his neck has bled twice after being snagged by a necklace.”	Covered
Suspicion of Malignancy	“Atypical, firm, and recently enlarged lesion; removal for histopathological exam is indicated.”	Covered
Obstruction of Vision	“Large 7mm tag on the left upper eyelid margin is partially obstructing the superior visual field.”	Covered

 

6.2. Common CPT® Codes for Skin Tag Removal

 

The CPT® code set has specific codes designed for the removal of skin tags. The choice of code is based on the number of lesions removed, not the method of removal.

• CPT® 11200: Removal of skin tags, multiple fibrocutaneous tags, any area; up to and including 15 lesions
  • This is the primary code used when 1 to 15 skin tags are removed in a single session.
• CPT® 11201: …each additional 10 lesions, or part thereof (List separately in addition to code for primary procedure)
  • This is an “add-on” code. It can only be used in conjunction with 11200.
  • Example: If 20 skin tags are removed, you would bill:
    • CPT 11200 (for the first 15)
    • CPT 11201 (for the additional 5)
  • If 28 tags are removed, you would bill:
    • CPT 11200 (for the first 15)
    • CPT 11201 x 2 (one unit for lesions 16-25, and one unit for lesions 26-28)

 

6.3. When Other CPT® Codes Might Apply

 

It is generally incorrect to use other lesion removal codes for simple skin tags.

• Shave Removal (11300-11313 series): These codes are for the shave removal of epidermal or dermal lesions (e.g., moles, seborrheic keratoses) without a full-thickness excision. They are categorized by location and size. Using these for a simple snip excision of a skin tag is typically considered incorrect.
• Excision (11400-11646 series): These codes are for full-thickness excision of benign or malignant lesions, which usually involves cutting through the dermis to the subcutaneous fat and requires suture closure. This is more extensive than what is required for a typical skin tag and would be inappropriate unless the lesion was highly suspicious and a deep biopsy was needed.

 

6.4. The Role of Modifiers

 

Modifiers are two-digit codes added to a CPT® code to provide additional information about the service.

• Modifier 25: Significant, Separately Identifiable E/M Service
  • This is one of the most important (and audited) modifiers. It is used when a significant Evaluation and Management (E/M) service (like a new patient visit or an established patient visit for a separate problem) is performed on the same day as a minor procedure like skin tag removal.
  • Correct Use: A patient comes in for management of their hypertension. During the visit, they also ask you to look at a painful skin tag. You perform a full workup for the hypertension (an E/M service) and also decide to remove the skin tag (a procedure). You could bill the E/M code with a -25 modifier and the CPT 11200.
  • Incorrect Use: A patient comes in only for the removal of a painful skin tag. The decision to remove the tag is part of the pre-operative work for the procedure itself and is not a separate E/M service. You cannot bill for both an E/M and the procedure in this case.
• Modifier 59: Distinct Procedural Service
  • This modifier is used to indicate that two procedures that are not normally reported together were performed at different anatomical sites or during different patient encounters on the same day. For example, if you removed a skin tag (11200) and also performed a shave biopsy of a different, suspicious lesion (e.g., 11300) at a separate body site during the same visit.

 

Chapter 6: Beyond the Code: Treatment and Management of Skin Tags

 

While the focus of this guide is on coding and documentation, it is useful to understand the clinical management of skin tags, as the chosen method of removal is what generates the CPT® code.

 

7.1. At-Home Removal: Risks and Complications

 

Many patients are tempted to remove skin tags at home using unproven over-the-counter products or by attempting to cut them off with scissors or tie them off with a string. Healthcare professionals should advise against this due to significant risks:

• Bleeding: The fibrovascular core can bleed heavily.
• Infection: Non-sterile instruments or an unclean environment can lead to a skin infection.
• Incomplete Removal: May lead to regrowth or scarring.
• Misdiagnosis: The most significant risk is removing a lesion that is not a skin tag but a skin cancer, thereby delaying a correct diagnosis and treatment.

 

7.2. Professional Removal Techniques

 

A clinician will choose a method based on the size, location, and number of tags. As noted previously, the CPT® codes 11200/11201 are based on number, not method.

• Snip Excision (Scissor Excision): The most common method. The practitioner uses fine, sterile scissors to snip the tag off at its base. A local anesthetic may be used for larger tags. Hemostasis is achieved with pressure, aluminum chloride, or light electrocautery.
• Cryosurgery: Liquid nitrogen is applied to the skin tag, freezing and destroying the tissue. The tag will then shrivel and fall off within one to two weeks. This is effective for multiple small tags.
• Electrodessication and Fulguration: An electric current is used to burn (cauterize) the tissue of the skin tag. This method provides excellent hemostasis and is very effective.
• Ligation: A surgical thread is tied tightly around the base of the tag’s stalk, cutting off its blood supply. The tag necroses and falls off after several days.

 

7.3. Prevention and Management Strategies

 

While there is no guaranteed way to prevent skin tags, especially if there is a strong genetic predisposition, certain strategies may help reduce their number or growth, particularly for those related to metabolic issues:

• Weight Management: Since obesity is a major risk factor, maintaining a healthy weight may reduce the likelihood of developing new tags.
• Blood Sugar Control: For individuals with insulin resistance or diabetes, improved glycemic control may help mitigate the growth-promoting effects of high insulin levels.
• Minimizing Friction: Wearing loose-fitting clothing and avoiding chunky jewelry that rubs on the neck may help reduce the mechanical trigger in susceptible individuals.

 

8. Conclusion: Synthesizing the Data

 

The accurate coding for a skin tag is a process that relies on a deep understanding of clinical medicine, the intricate rules of the ICD-10-CM system, and the financial realities of medical billing. The primary diagnosis code is L91.8 (Other hypertrophic disorders of the skin), but this must be supported by meticulous documentation that clearly establishes medical necessity through symptoms of irritation, pain, or bleeding to ensure reimbursement. Ultimately, precise documentation is the crucial link that connects a common clinical finding to a successfully paid claim.

 

9. Frequently Asked Questions (FAQs)

 

Q1: What is the single ICD-10 code for a common skin tag? A1: The most common and correct ICD-10-CM code for a skin tag (acrochordon or fibroepithelial polyp) is L91.8, Other hypertrophic disorders of the skin.

Q2: Can I get my skin tags removed for free? Will my insurance cover it? A2: Insurance will only cover the removal of skin tags if it is deemed “medically necessary.” This means the tag must be causing symptoms like pain, catching on clothing, bleeding, or be inflamed. Removal for purely cosmetic reasons is an out-of-pocket expense.

Q3: My doctor wants to send my removed skin tag to a lab. Is this normal? A3: Yes, it is very common and good medical practice to send any removed skin lesion for histopathological examination. This confirms the diagnosis is indeed a benign skin tag and definitively rules out the small possibility of it being something more serious, like a skin cancer.

Q4: What is the CPT code for skin tag removal? A4: The primary CPT codes are 11200 (for removal of up to 15 skin tags) and the add-on code 11201 (for each additional 10 lesions). The code is based on the number of tags removed, not the method used.

Q5: I have a skin tag on my eyelid. Is the ICD-10 code still L91.8? A5: No. For skin tags on the eyelid, you should use a more specific code from the H02.82- series (e.g., H02.821 for the right upper eyelid), as codes for specific anatomical sites take precedence. Similarly, for perianal skin tags, the correct code is K64.5.

Q6: What is the difference between an ICD-10 code and a CPT code? A6: An ICD-10 code is a diagnosis code; it answers the question, “What is wrong with the patient?” (e.g., L91.8, skin tag). A CPT code is a procedure code; it answers the question, “What did the doctor do about it?” (e.g., 11200, removal of skin tags). Both are required on a claim form for reimbursement.

---

 

10. Additional Resources

 

• Centers for Disease Control and Prevention (CDC) – ICD-10-CM: The official source for the ICD-10-CM classification system and guidelines.
  • https://www.cdc.gov/nchs/icd/icd-10-cm.htm
• American Academy of Professional Coders (AAPC): A leading organization for medical coding training, certification, and resources.
  • https://www.aapc.com/
• American Medical Association (AMA) – CPT® Code Information: The official source for the CPT® coding system.
  • https://www.ama-assn.org/practice-management/cpt
• American Academy of Dermatology (AAD): Provides clinical information and patient resources on skin tags and other dermatological conditions.
  • https://www.aad.org/

 

 

Date: September 17, 2025
Author: The Medical Coding Specialist Team
Disclaimer: This article is intended for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. The codes and guidelines referenced are subject to change; always refer to the most current official ICD-10-CM coding manuals and payer-specific policies for accurate billing and reimbursement.